Caplyta in Borderline Personality Disorder
Clinical trial NCT05356013 · COMPLETED
Trial details
- NCT number
- NCT05356013
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2025-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.